Company Filing History:
Years Active: 2005
Title: Edda Tobiasch: Pioneering Innovation in Early Abortion Diagnostics
Introduction: Edda Tobiasch, an accomplished inventor based in Dossenheim, Germany, has made significant contributions to the field of medical diagnostics. With a focus on understanding and addressing spontaneous early abortion, she holds a patent that demonstrates her dedication to improving health outcomes for women.
Latest Patents: Edda Tobiasch is credited with a patent titled "Adeno-associated virus - its diagnostic use with early abortion." This innovative invention involves a method for detecting the causative agent of spontaneous early abortion by analyzing patient samples for the presence of adeno-associated virus DNA (AAV DNA), AAV antigens, or antibodies, particularly those of the IgM type directed toward AAV. Additionally, her patent encompasses antibodies suitable for this diagnostic method, highlighting her significant impact on the field.
Career Highlights: Edda Tobiasch is affiliated with the Deutsche Krebsforschungszentrum (German Cancer Research Center), where she has continued to advance her research and contribute to the understanding of viral implications in reproductive health. Her work reflects a deep commitment to scientific advancement and patient care.
Collaborations: Within her research environment, Edda collaborates closely with esteemed coworkers Andrea Kern and Jürgen Kleinschmidt. Together, they leverage their combined expertise to explore innovative solutions in the realm of medical diagnostics and beyond.
Conclusion: Edda Tobiasch's groundbreaking patent work on the diagnostic use of adeno-associated virus stands as a testament to her ingenuity and dedication as an inventor. Her contributions not only enhance scientific knowledge but also hold the potential to transform clinical practice in treating early abortion-related challenges.